Durvalumab after concurrent chemoradiotherapy for sensitizing epidermal growth factor receptor-mutant stage III non-small cell lung cancer: A Japanese Real-World data analysis
Durvalumab administration following CCRT prolongs PFS in patients with locally advanced EGFR-mutant NSCLC. Durvalumab can be safely administered if the timing of subsequent osimertinib is carefully managed.
Authors
- Ayako Takigami
- Satoshi Takahashi (ORCID: https://orcid.org/0009-0006-0733-6094)
- Makoto Maemondo (ORCID: https://orcid.org/0000-0002-1950-1943)
- Gen Kida
- Eisaku Miyauchi (ORCID: https://orcid.org/0000-0002-6837-6392)
- Ken Masuda (ORCID: https://orcid.org/0000-0002-7736-3737)
- Akira Nakao (ORCID: https://orcid.org/0000-0001-8308-4227)
- Hajime Kikuchi
- Motohiro Tamiya (ORCID: https://orcid.org/0000-0001-6529-3092)
- Kazuhiro Nishiyama
- Yukari Tsubata (ORCID: https://orcid.org/0000-0002-4260-2849)
- Toshiya Fujisaki (ORCID: https://orcid.org/0000-0003-4305-3455)
- Yoshiaki Nagai (ORCID: https://orcid.org/0000-0001-9466-8324)
- Daisuke Arai (ORCID: https://orcid.org/0000-0002-9046-6300)
- Satoshi Watanabe (ORCID: https://orcid.org/0000-0001-6757-3514)
- Yu Miura (ORCID: https://orcid.org/0000-0002-2752-5873)
- Hironori Ashinuma (ORCID: https://orcid.org/0000-0002-5277-5233)
- Ken Masubuchi (ORCID: https://orcid.org/0000-0001-7440-441X)
- Satoshi Morita (ORCID: https://orcid.org/0000-0002-4344-3317)
- Taichi Miyawaki
- Kana Watanabe (ORCID: https://orcid.org/0000-0001-5139-5901)
Institutions
- Jichi Medical University (JP)
- St. Marianna University School of Medicine (JP)
- Shimane University (JP)
- Kyoto University (JP)
- Juntendo University (JP)
- Fukuoka University Hospital (JP)
- Tohoku University Hospital (JP)
- Tachikawa Medical Center (JP)
- Miyagi Prefectural Hospital Organization (JP)
- Hiroshima Prefectural Hospital (JP)
- Tokyo Medical University Hospital (JP)
- Obihiro Kosei General Hospital (JP)
- Chiba Cancer Center (JP)
- Saiseikai Utsunomiya hospital (JP)
- Saitama Cancer Center (JP)
- Osaka International Cancer Institute (JP)
- Hyogo Prefectural Cancer Center (JP)
- Jichi Medical University Saitama Medical Center (JP)
- Niigata University (JP)
- Saitama Medical University (JP)
Publication Details
- Journal
- Lung Cancer
- Published
- 2025-05-27
- DOI
- https://doi.org/10.1016/j.lungcan.2025.108597
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00